In the next chapter we explore more about the major players in the drug development ecosystem, as well as the financial aspects of drug development.
For now, we’d just like to introduce you to those major players. These entities collaborate and interact within a complex ecosystem, contributing different expertise and resources in order to develop and deliver safe and effective drugs to patients.
Academic and Research Institutions:
Universities, research centers, and academic institutions often conduct fundamental research that contributes to the discovery of new drug targets, technologies, and basic scientific understanding that forms the basis for drug development.
Government Agencies and Funding
Bodies:
Government agencies (especially the National Institutes of Health - NIH) provide grants and funding for research, supporting academic institutions and researchers working on various aspects of drug discovery and development.
Investors and Venture Capital Firms:
Investors provide funding for research and development efforts of pharmaceutical and biotechnology companies. Venture capital firms often invest in early-stage companies working on innovative drug candidates.
Biopharmaceutical Companies:
These companies conduct research, discover potential drug candidates, conduct preclinical and clinical trials, and seek regulatory approvals for new drugs.
Contract Research Organizations (CROs)
& Research Technology Service Providers:
Numerous contract service providers play a pivotal role in supporting pharmaceutical and biotech companies by aiding in different phases of drug development. They assist in several critical areas, like providing essential materials, conducting preliminary research, managing clinical trials, handling data, and ensuring compliance with regulatory standards.